Lifevantage (NASDAQ:LFVN) Announces Earnings Results, Misses Estimates By $0.01 EPS

Lifevantage (NASDAQ:LFVN) posted its quarterly earnings data on Monday. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.01), FiscalAI reports. Lifevantage had a net margin of 2.78% and a return on equity of 21.56%. The business had revenue of $37.12 million for the quarter, compared to analysts’ expectations of $40.49 million.

Here are the key takeaways from Lifevantage’s conference call:

• Revenue and earnings fell sharply: First-quarter revenue declined 22% year over year to $37.1 million as orders and average order size decreased. Adjusted EBITDA fell to $1.9 million from $3.9 million, and the company reported a GAAP operating loss.
• Management laid out a broad transformation plan focused on repositioning the brand, improving the digital consumer experience, and making the business more efficient. Planned launches include a new North American website and digital platform in calendar Q2 2027, followed by seller tools in Q3.
• The company has a solid financial cushion: It ended the quarter with $13.7 million in cash, no debt, and $0.5 million in cash from operations. Management said it expects operating cash flow to remain positive.
• Subscription-based sales represented more than 75% of revenue, and management reported improved customer and consultant retention compared with the prior-year quarter. However, the company is not providing formal guidance while it works through its strategy and fiscal-year transition.

Lifevantage Stock Up 1.3%

Shares of NASDAQ LFVN traded up $0.07 on Monday, reaching $5.29. 31,131 shares of the company’s stock traded hands, compared to its average volume of 216,061. Lifevantage has a 12 month low of $3.90 and a 12 month high of $11.71. The business’s 50 day simple moving average is $6.06 and its two-hundred day simple moving average is $5.88. The company has a market cap of $66.60 million, a price-to-earnings ratio of 13.22 and a beta of 0.71.

Lifevantage Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a dividend of $0.05 per share. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.8%. Lifevantage’s dividend payout ratio (DPR) is currently 50.00%.

Insider Activity at Lifevantage

In other news, insider Kristen Cunningham sold 8,901 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $6.18, for a total value of $55,008.18. Following the sale, the insider directly owned 120,162 shares of the company’s stock, valued at $742,601.16. The trade was a 6.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 13.58% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on LFVN shares. Lake Street Capital raised their target price on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, August 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Finally, Zacks Research cut Lifevantage from a “hold” rating to a “strong sell” rating in a research note on Friday, October 16th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $5.50.

About Lifevantage

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care.

The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets.